Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Free Report) shot up 1.9% on Wednesday . The company traded as high as $3.57 and last traded at $3.28. 16,082 shares changed hands during trading, a decline of 96% from the average session volume of 451,868 shares. The stock had previously closed at $3.22.
Lixte Biotechnology Stock Up 1.9 %
The company has a market cap of $7.38 million, a P/E ratio of -1.21 and a beta of -0.28. The stock has a 50 day moving average price of $2.84 and a two-hundred day moving average price of $2.55.
Lixte Biotechnology (NASDAQ:LIXT – Get Free Report) last posted its quarterly earnings data on Tuesday, March 19th. The company reported ($0.41) EPS for the quarter.
About Lixte Biotechnology
Lixte Biotechnology Holdings, Inc operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.
Featured Stories
- Five stocks we like better than Lixte Biotechnology
- What is Forex and How Does it Work?
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Calculate Options Profits
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Lixte Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lixte Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
